Hikma Pharmaceuticals PLC (HIK) — Cash Flow Reinvestment Rate
Hikma Pharmaceuticals PLC (HIK) has a Cash Flow Reinvestment Rate of 0.42x as of June 2025, reinvesting GBX68.00 Million (capex GBX68.00 Million ) from operating cash flow of GBX161.00 Million. Explore Hikma Pharmaceuticals PLC capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hikma Pharmaceuticals PLC Cash Flow Reinvestment Rate (2002–2024)
Historical reinvestment intensity for Hikma Pharmaceuticals PLC across 23 annual periods. Also explore Hikma Pharmaceuticals PLC assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hikma Pharmaceuticals PLC (2002–2024)
Year-by-year capital reinvestment analysis for Hikma Pharmaceuticals PLC. For live market cap and broader valuation context, see HIK market cap overview.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.97x | GBX546.00 Million | GBX564.00 Million | GBX165.00 Million | ▲ +17.3% |
| 2023 | 0.83x | GBX502.00 Million | GBX608.00 Million | GBX169.00 Million | ▼ -47.4% |
| 2022 | 1.57x | GBX832.00 Million | GBX530.00 Million | GBX225.00 Million | ▲ +114.5% |
| 2021 | 0.73x | GBX467.00 Million | GBX638.00 Million | GBX229.00 Million | ▲ +49.6% |
| 2020 | 0.49x | GBX227.00 Million | GBX464.00 Million | GBX224.00 Million | ▲ +19.0% |
| 2019 | 0.41x | GBX194.00 Million | GBX472.00 Million | GBX186.00 Million | ▲ +59.2% |
| 2018 | 0.26x | GBX111.00 Million | GBX430.00 Million | GBX107.00 Million | ▼ -0.6% |
| 2017 | 0.26x | GBX115.00 Million | GBX443.00 Million | GBX107.00 Million | ▼ -90.7% |
| 2016 | 2.79x | GBX817.00 Million | GBX293.00 Million | GBX122.00 Million | ▲ +890.8% |
| 2015 | 0.28x | GBX103.00 Million | GBX366.00 Million | GBX82.00 Million | ▲ +6.8% |
| 2014 | 0.26x | GBX112.00 Million | GBX425.00 Million | GBX91.00 Million | ▲ +5.7% |
| 2013 | 0.25x | GBX84.00 Million | GBX337.00 Million | GBX59.00 Million | ▼ -49.7% |
| 2012 | 0.50x | GBX90.19 Million | GBX182.16 Million | GBX90.19 Million | ▼ -34.8% |
| 2011 | 0.76x | GBX78.00 Million | GBX102.64 Million | GBX78.00 Million | ▲ +98.3% |
| 2010 | 0.38x | GBX53.20 Million | GBX138.79 Million | GBX53.20 Million | ▲ +0.2% |
| 2009 | 0.38x | GBX40.38 Million | GBX105.52 Million | GBX40.38 Million | ▼ -66.2% |
| 2008 | 1.13x | GBX65.52 Million | GBX57.87 Million | GBX65.52 Million | ▼ -11.2% |
| 2007 | 1.28x | GBX54.99 Million | GBX43.12 Million | GBX54.99 Million | ▼ -27.1% |
| 2006 | 1.75x | GBX52.44 Million | GBX29.99 Million | GBX52.44 Million | ▲ +138.5% |
| 2005 | 0.73x | GBX23.98 Million | GBX32.71 Million | GBX23.98 Million | ▲ +12.9% |
| 2004 | 0.65x | GBX21.33 Million | GBX32.84 Million | GBX21.33 Million | — |
| 2003 | 0.00x | GBX0.00 | GBX18.35 Million | GBX0.00 | — |
| 2002 | 0.00x | GBX0.00 | GBX14.35 Million | GBX0.00 | — |